Saniea Majid, MD
Surgery · Livingston, NJNPI 1932344348
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Johnson & Johnson at 59.4% of the total. 2025 is the largest year on record at $29,405, 6.9 times the $4,285 reported in 2019. Among surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 141 payments — averaging $280.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$24K
- Medical Device Business Services, Inc.$7K
- W. L. Gore & Associates, Inc.$3K
- Boston Scientific$1K
- Medtronic$1K
- Covidien LP$1K
- plus $3K from 10 others
What the payments were for
- Consulting fees$23,01958%
- Travel & lodging$11,41829%
- Food & beverage$5,08913%
- Education$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 14 | $23,501 |
| Medical Device Business Services, Inc. | 41 | $7,033 |
| W. L. Gore & Associates, Inc. | 17 | $2,558 |
| Boston Scientific | 8 | $1,158 |
| Medtronic | 9 | $1,128 |
| Covidien LP | 3 | $1,121 |
| Apollo Endosurgery US Inc | 8 | $829 |
| Intuitive Surgical | 8 | $805 |
| Enterra Medical, Inc. | 2 | $765 |
| Novo Nordisk | 19 | $399 |
| Lilly USA, LLC | 3 | $80 |
| AstraZeneca | 1 | $76 |
| Currax Pharmaceuticals LLC | 3 | $43 |
| Vivus LLC | 2 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $25 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ECHELON ENDOPATH$23,125
- STRATAFIX$2,468
- Echelon Flex$1,237
- X-Tack Endoscopic HeliX Tacking System$1,163
- SEAMGUARD Bioabsorbable Staple Line Reinforcement$1,098
- HARMONIC Product Family$1,072
- ECHELON FLEX Stapler$1,072
- Sonicision$970
- APOLLO ESG System$965
- Da Vinci Surgical System$669
- BIO-A Tissue Reinforcement$595
- OverStitch Endoscopic Suturing System$581
- Signia$294
- LigaSure$253
- GORE BIO-A Tissue Reinforcement$180
- SURGICEL NU-KNIT$149
- Wegovy$117
- BIO-A Hernia Plug$107
How this compares
$39,572 in reported general payments places this provider in the 95th percentile of 593 surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 61 | $62,940 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $80 | $62,94061 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 593 surgery providers in New Jersey.
Other surgery in Livingston
- Prakash ParagiLivingston$19K
- Robert PerezHainesport$2M
- Eric WhitmanMorristown$848K
- Jarrod KaufmanBrick$474K
- Amit TrivediParamus$242K
- Young HongCamden$203K
- Harvey RainvilleGlen Ridge$159K
- Harrison CotlerOakhurst$149K
- Francis PrevitiNorth Field$131K
- David DupreeTinton Falls$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.